All Insights
Showing 1 - 12 of 228
GDPR for HR
GDPR for HR | March 2026
Data protection in internal investigations, use of AI in DSARs and recruitment, and deleted data DSAR obligations
Regulatory Outlook
Consumer law | UK Regulatory Outlook March 2026
CMA sets out consumer law expectations for businesses deploying AI agents | Commencement of DMCCA alternative dispute resolution regime |
Regulatory Outlook
Artificial intelligence | UK Regulatory Outlook March 2026
UK government position on copyright and AI | Lords Communications and Digital Committee calls on government to reject opt-out model
Intellectual property
Opted out: UK government moves away from preferred position on AI and copyright following report
No concrete policy decisions made; wide text and data mining copyright exception with opt-out no longer preferred approach; more information
Dispute resolution
AI tools and privilege in the UK – what are the risks?
Upper Tribunal gives strict warning on the privilege risks when using AI, distinguishing between 'open source' and closed tools
Regulatory and compliance
The regulation of consumer robotics
What are the implications for manufacturers?
Intellectual property
Supreme Court opens the door in the UK to patentability of AI inventions
UK brought into alignment with EPO as domestic approach to patentability of computer-implemented inventions overturned
Regulatory Outlook
Artificial intelligence | UK Regulatory Outlook February 2026
UK: AI Opportunities Action Plan: one year on | AI and copyright: recent comments from the government | New criminal
Life Sciences and Healthcare
Data-driven digital health businesses challenged with balancing AI advances and tighter regulation in 2026
Hyper-personalisation, data interoperability and AI are among 2025's fast-evolving areas to continue to watch this year
Life Sciences and Healthcare
EU MDR and IVDR poised to remain main framework for medical AI in draft AI interface reforms
Lex specialis treatment, integrated notified body reviews and clarified duties are designed to limit overlapping regulation of medical AI
Life Sciences and Healthcare
Planned EU medtech changes and codified Helsinki procedure support consistent qualification and classification
EU coordination, expert panel opinions and targeted down classification are proposed to harmonise risk based outcomes
Corporate
Confidence in a changing global market: 2025 dealmaking themes and 2026 market opportunities
The global transactional market demonstrated resilience amid complexity in 2025 as it staged a measured recovery
